amlodipine has been researched along with quercetin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Ahmed, LA; Attia, AS; El-Sayed, ME; Salem, HA | 1 |
Furtműller, PG; Hubčík, L; Mučaji, P; Nagy, M; Toca-Herrera, JL; Valentová, J; Vaneková, Z | 1 |
Prokosa, MI | 1 |
5 other study(ies) available for amlodipine and quercetin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Enhancement of amlodipine cardioprotection by quercetin in ischaemia/reperfusion injury in rats.
Topics: Amlodipine; Animals; Antioxidants; Arrhythmias, Cardiac; Cardiotonic Agents; Drug Evaluation, Preclinical; Drug Therapy, Combination; Heart Rate; Heart Ventricles; Male; Myocardial Reperfusion Injury; Quercetin; Random Allocation; Rats; Vasodilator Agents | 2009 |
Study of Interactions between Amlodipine and Quercetin on Human Serum Albumin: Spectroscopic and Modeling Approaches.
Topics: Amlodipine; Drug Interactions; Humans; Models, Molecular; Molecular Conformation; Molecular Structure; Protein Binding; Quantitative Structure-Activity Relationship; Quercetin; Serum Albumin, Human; Spectrum Analysis | 2019 |
INDICATORS OF ENDOTHELIAL DYSFUNCTION, MARKERS OF INFLAMMATION AND LIPID METABOLISM IN PATIENTS WITH HYPERTENSION WITH THE ADMINISTRATION OF QUERCETIN.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Inflammation; Interleukin-1; Lipid Metabolism; Male; Middle Aged; Nitric Oxide; Quercetin; Ramipril | 2022 |